First line antiretroviral treatment failure and associated factors among people living with HIV in northwest Ethiopia
- PMID: 34394306
- PMCID: PMC8356610
- DOI: 10.4314/ahs.v21i1.34
First line antiretroviral treatment failure and associated factors among people living with HIV in northwest Ethiopia
Abstract
Background: Anti-retroviral treatment enhances the immune status and reduces unwanted outcomes. However, development of treatment failure and drug resistance raises concern over lifelong treatments to chronic diseases such as HIV/AIDS.
Objectives: This study determined proportion of treatment failure (TF) and identified factors associated with TF among people living with human immunodeficiency virus (HIV) in Bahir Dar, Northwest Ethiopia.
Methods: Facility based cross sectional study was carried out from November, 2017 to April, 2018. Sociodemographic and clinical data were collected using structured questioner. Blood sample was collected and analyzed for viral load, complete blood count (CBC), liver and kidney function test and CD4 count. A patient is declared as treatment failure when viral load value is higher than 1000 RNA copies/ml in two consecutive viral load analyses within three months interval. Data were entered and analyzed using SPSS version 23. To identify factors associated with TF, logistic regressions model was employed.
Results: A total of 430 people who had six months and above antiretroviral treatment (ART) follow up were enrolled in the study. Of these, 57.9% were females & the mean age was 38 years. The mean month of ART follow up was 83 months. In the first viral load analysis, 106 (24.7%) of the cohort were virologically failed. These failed people were followed for 3 months with intensive adherence support; then second viral load analysis showed a viralogical failure among 65 people of the second cohort. Thus, the overall viralogical failure or TF was 15.1%. The re-suppression rates were 41(38.7%). Male gender, people with history of drug discontinuation, poor adherence, irregular time of drug intake, multiple sexual practice showed significant association with TF. Moreover, base line and current CD4 counts of <200 cells/ml also demonstrated significant association with TF.
Conclusion: Significant proportion of treatment failure was reported in the present study. Moreover, behavioral factors such as drug discontinuation, poor adherence, multiple sexual partner were associated with treatment failure. Hence, to avoid TF, regular patient counseling and monitoring should be in place. To identify the predictors for treatment failure, further follow-up study is desirable.
Keywords: Ethiopia; HIV; treatment failure; viral load.
© 2021 Genet A et al.
Figures
Similar articles
-
Predictive factors associated with virological failure among adult patients living with HIV on first-line highly active antiretroviral therapy in Southeast Oromia, Ethiopia: a case-control study.BMJ Open. 2025 Apr 17;15(4):e093797. doi: 10.1136/bmjopen-2024-093797. BMJ Open. 2025. PMID: 40250876 Free PMC article.
-
Viral load suppression and its predictor among HIV seropositive people who receive enhanced adherence counseling at public health institutions in Bahir Dar, Northwest Ethiopia. Retrospective follow-up study.PLoS One. 2024 May 13;19(5):e0303243. doi: 10.1371/journal.pone.0303243. eCollection 2024. PLoS One. 2024. PMID: 38739646 Free PMC article.
-
Antiretroviral treatment failure and associated factors among HIV patients on first-line antiretroviral treatment in Sekota, northeast Ethiopia.AIDS Res Ther. 2020 Jul 10;17(1):39. doi: 10.1186/s12981-020-00294-z. AIDS Res Ther. 2020. PMID: 32650796 Free PMC article.
-
[Consensus document of Gesida and Spanish Secretariat for the National Plan on AIDS (SPNS) regarding combined antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2012)].Enferm Infecc Microbiol Clin. 2012 Jun;30(6):e1-89. doi: 10.1016/j.eimc.2012.03.006. Epub 2012 May 23. Enferm Infecc Microbiol Clin. 2012. PMID: 22633764 Spanish.
-
[National consensus document by GESIDA/National Aids Plan on antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2011 update)].Enferm Infecc Microbiol Clin. 2011 Mar;29(3):209.e1-103. doi: 10.1016/j.eimc.2010.12.004. Enferm Infecc Microbiol Clin. 2011. PMID: 21388714 Spanish.
Cited by
-
Drug-Related Problems in HIV Treatment Failure.Cureus. 2024 Sep 21;16(9):e69838. doi: 10.7759/cureus.69838. eCollection 2024 Sep. Cureus. 2024. PMID: 39435225 Free PMC article.
-
Non communicable diseases persist despite being overshadowed by Covid-19 globally.Afr Health Sci. 2021 Mar;21(1):i-iv. doi: 10.4314/ahs.v21i1.1. Afr Health Sci. 2021. PMID: 34394331 Free PMC article. No abstract available.
-
Higher Genotyping Performance of the Applied Biosystems TaqPath Seq HIV-1 Genotyping Kit Against ViroSeq HIV-1 Genotyping Kit in HIV Protease, Reverse Transcriptase, and Integrase Regions.Infect Drug Resist. 2025 Apr 13;18:1847-1858. doi: 10.2147/IDR.S488722. eCollection 2025. Infect Drug Resist. 2025. PMID: 40247893 Free PMC article.
-
Magnitude of Viral Load Suppression and Associated Factors among Clients on Antiretroviral Therapy in Public Hospitals of Hawassa City Administration, Ethiopia.HIV AIDS (Auckl). 2022 Nov 18;14:529-538. doi: 10.2147/HIV.S387787. eCollection 2022. HIV AIDS (Auckl). 2022. PMID: 36425750 Free PMC article.
-
Prior antiretroviral therapy exposure among clients presenting for HIV treatment initiation in South Africa: an exploratory mixed-methods study using multiple indicators of exposure.BMC Infect Dis. 2025 Jul 26;25(1):947. doi: 10.1186/s12879-025-11340-4. BMC Infect Dis. 2025. PMID: 40713520 Free PMC article.
References
-
- HIV/AIDS UNPo, author. Global AIDS update. 2016. Updated July. 2016.
-
- Godfrey C, Thigpen MC, Crawford KW, Jean-Phillippe P, Pillay D, Persaud D, et al. Global HIV antiretroviral drug resistance: a perspective and report of a national institute of allergy and infectious diseases consultation. The Journal of Infectious Diseases. 2017;216(suppl_ 9):S798–S800. p. S798-S800. - PMC - PubMed
-
- Federal Ministry of Health, Ethiopia, author; HIV/AIDS, editor. National Guidelines for Comprehensive HIV Prevention, Care and Treatment. Addis Ababa: MoH; 2017.
-
- Arimide DA, Abebe A, Kebede Y, Adugna F, Tilahun T, Kassa D, et al. HIV-genetic diversity and drug resistance transmission clusters in Gondar, Northern Ethiopia, 2003–2013. 2018;13(10):e0205446. p.e0205446. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6179264/pdf/pone.0205446.pdf. - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous